Published in Schweiz Rundsch Med Prax on January 15, 1980
The effect of the gastrointestinal lipase inhibitor, orlistat, on serum lipids and lipoproteins in patients with primary hyperlipidaemia. Eur J Clin Pharmacol (1994) 2.04
Identification of a distinct human high-density lipoprotein subspecies defined by a lipoprotein-associated protein, K-45. Identity of K-45 with paraoxonase. Eur J Biochem (1993) 1.57
Characterization of subpopulations of lipoprotein particles isolated from human cerebrospinal fluid. Biochim Biophys Acta (1995) 1.16
Quantification of human serum paraoxonase by enzyme-linked immunoassay: population differences in protein concentrations. Biochem J (1994) 1.15
Apolipoprotein B metabolism in homozygous familial hypercholesterolemia. J Lipid Res (1989) 1.09
Asymptomatic bacteriuria in diabetes mellitus. N Engl J Med (1967) 1.05
Low density lipoprotein causes general cellular activation with increased phosphatidylinositol turnover and lipoprotein catabolism. Proc Natl Acad Sci U S A (1988) 1.00
Differences in lipoprotein subfraction composition and distribution between type I diabetic men and control subjects. Diabetes (1990) 0.96
Relationship between plasma insulin levels and high density lipoprotein cholesterol levels in healthy men. Diabetologia (1981) 0.95
Characterization of a human high density lipoprotein-associated protein, NA1/NA2. Identity with SP-40,40, an inhibitor of complement-mediated cytolysis. Arterioscler Thromb (1991) 0.94
Protein heterogeneity of lipoprotein particles containing apolipoprotein A-I without apolipoprotein A-II and apolipoprotein A-I with apolipoprotein A-II isolated from human plasma. J Lipid Res (1988) 0.90
Quantitative studies on the lipolytic response of human subcutaneous and omental adipose tissue to noradrenaline and theophylline. Acta Med Scand (1969) 0.86
Treatment of hyperlipoproteinemia (HLP) type II A with a new phenoxy-isobuturic acid derivative, procetofen. Int J Clin Pharmacol Biopharm (1979) 0.85
[Dyslipidemia in the diabetic patient. Recommendations of ALFEDIAM (French Language Association for the Study of Diabetes and Metabolic Diseases)]. Diabete Metab (1995) 0.85
Lipoprotein (a) and vascular disease in diabetic patients. Diabetologia (1995) 0.83
Immunoaffinity fractionation of high-density lipoprotein subclasses 2 and 3 using anti-apolipoprotein A-I and A-II immunosorbent gels. Biochim Biophys Acta (1989) 0.82
[Maximum gastric stimulation with the augmented histamine test in healthy children]. Helv Paediatr Acta (1969) 0.82
HDL particle associated proteins in plasma and cerebrospinal fluid: identification and partial sequencing. Appl Theor Electrophor (1988) 0.81
Iron excess, early glucose intolerance and impaired insulin secretion in idiopathic haemochromatosis. Eur J Clin Invest (1973) 0.81
Liver glycerokinase deficiency in man with hyperglycerolaemia and hypertriglyceridaemia. Eur J Clin Invest (1984) 0.81
Distribution of apolipoprotein E between free and A-II complexed forms in very-low- and high-density lipoproteins: functional implications. Biochim Biophys Acta (1991) 0.81
Effect of nicotinic acid on ACTH and noradrenaline stimulated lipolysis in the rabbit. II. In vitro studies including comparison with prostaglandin E1. Acta Physiol Scand (1970) 0.81
HDL lipids in close relatives of coronary heart disease patients. Environmental and genetic influences. Atherosclerosis (1979) 0.81
Metabolic effects of dietary fiber from dehulled soybeans in humans. Am J Clin Nutr (1983) 0.80
Immunofractionation of high density lipoprotein subclasses 2 and 3. Similarities and differences of fractions isolated from male and female populations. Atherosclerosis (1990) 0.80
[Apoprotein E (apo E) phenotype and serum lipids in diabetics]. Schweiz Med Wochenschr (1987) 0.79
Phenotyping is an accurate means of analysing the principal apolipoprotein E isoforms. Clin Chim Acta (1994) 0.78
Fat mobilizing lipolysis and levels of cyclic AMP in human and dog adipose tissue. Acta Med Scand (1970) 0.78
The distribution profiles of very low density and low density lipoproteins in poorly-controlled male, type 2 (non-insulin-dependent) diabetic patients. Diabetologia (1991) 0.78
High density lipoprotein cholesterol in male relatives of patients with coronary heart disease. Atherosclerosis (1979) 0.78
Apolipoprotein E polymorphism as a risk factor for vascular disease in diabetic patients. Diabetes Care (1995) 0.78
Postprandial lipemia differentially influences high density lipoprotein subpopulations LpAI and LpAI,AII. J Lipid Res (1994) 0.78
Comparison of lipolysis in human subcutaneous and omental adipose tissue with regard to effects of noradrenaline, theophylline, prostaglandin E1 and age. Acta Chir Scand (1969) 0.78
Apoprotein D in a healthy, male population and in male myocardial infarction patients and their male, first-degree relatives. Atherosclerosis (1986) 0.77
Amino acids and lipoproteins in plasma of duodenopancreatectomized patients: effects of glucagon in physiological amounts. Eur J Clin Invest (1983) 0.77
Acquired (secondary) forms of hypertriglyceridemia. Am J Cardiol (1991) 0.77
HDL and coronary heart disease: a familial trend. Adv Exp Med Biol (1987) 0.77
Underexpression of the apolipoprotein E4 isoform in an Italian population. Arterioscler Thromb (1993) 0.77
Factors influencing the low density lipoprotein profile in type 2 diabetic patients. Diabet Med (1995) 0.77
Gender differences in a type 2 (non-insulin-dependent) diabetic population with respect to apolipoprotein E phenotype frequencies. Diabetologia (1993) 0.76
HDL cholesterol levels in patients with myocardial infarction and their families. Atherosclerosis (1986) 0.76
Decreased HDL cholesterol in prepubertal and pubertal children of CHD patients. Atherosclerosis (1980) 0.76
Effects of ocular carteolol and timolol on plasma high-density lipoprotein cholesterol level. Am J Ophthalmol (1994) 0.75
Marked changes of lipid levels during puberty in a patient with lipoprotein lipase deficiency. Eur J Pediatr (1997) 0.75
[Dyslipidemia in diabetes mellitus: significance, diagnosis and treatment]. Schweiz Rundsch Med Prax (1990) 0.75
[Dietary lipids and serum lipids in adolescents, based on the Geneva study of the precursors of atherosclerosis]. Soz Praventivmed (1984) 0.75
Interference of dimethyl alpha-(dimethoxyphosphinyl) p-chlorobenzyl phosphate (SR-202) in thyroid hormone metabolism: evidence of inhibition of monodeiodination. J Endocrinol (1987) 0.75
[Molecular pathophysiology of familial hypercholesterolemia]. Pol Tyg Lek (1985) 0.75
[Diet in the treatment of hyperlipidaemia (author's transl)]. Ther Umsch (1980) 0.75
[HDL-cholesterol and family incidence of coronary disease in the Genevan population]. Schweiz Med Wochenschr (1983) 0.75
[Drug therapy of hyperlipoproteinemias]. Ther Umsch (1980) 0.75
[The clinical importance of cardiovascular risk factors]. Schweiz Rundsch Med Prax (1992) 0.75
Some characteristics of lipolysis in rabbit adipose tissue. Effects of noradrenaline, ACTH, theophylline and prostaglandin E1. Acta Physiol Scand (1970) 0.75
Topical timolol maleate might adversely affect serum lipoproteins. Int Ophthalmol (1993) 0.75
Effect of prostaglandin E1 on fat mobilizing lipolysis in rat adipose tissue in relation to the nutritional condition. Acta Physiol Scand (1970) 0.75
[High-density lipoproteins in children with coronary diseases]. Helv Paediatr Acta (1981) 0.75
[Dietary treatment of the hyperlipidemias]. Ther Umsch (1986) 0.75
[Symposium on hiatal hernia in children. II. Physiology. 2. Problems of gastric acidity: gastro-esophageal reflux and gastric secretion in children]. Ann Chir Infant (1967) 0.75
Serum lipoprotein abnormalities in ischaemic heart disease. Postgrad Med J (1975) 0.75
[Serum lipoproteins in family members of myocardial infarct victims]. Soz Praventivmed (1978) 0.75
The influence of metabolic control on very low density lipoprotein composition in hypertriglyceridemic type II diabetics. A study using heparin-sepharose chromatography. Metabolism (1988) 0.75
Lipid, lipoprotein and APO-A and APO-B lipoprotein distribution in Italian and Swiss schoolchildren. The Geneva survey. Pediatr Res (1982) 0.75
Apparent lack of influence of the genetic drug oxidation status on plasma cholesterol concentration in man. Pharmacol Res Commun (1984) 0.75
[Dyslipidemias and diabetes mellitus]. Journ Annu Diabetol Hotel Dieu (1989) 0.75
Preparative isoelectrofocusing and high resolution 2-dimensional gel electrophoresis for concentration and purification of proteins. Appl Theor Electrophor (1991) 0.75
Geneva study on the precursors of atherosclerosis: first results. Soz Praventivmed (1979) 0.75
[Treatment of hyperlipemia with clofibrate in a case of nephrotic syndrome: secondary enzymatic and muscular alterations]. J Urol Nephrol (Paris) (1973) 0.75
Lipoprotein complexes in human cerebrospinal fluid. Schweiz Arch Neurol Psychiatr (1993) 0.75
[Comparison of 2 cholesterol synthesis inhibitors (simvastatin and pravastatin)]. Schweiz Med Wochenschr (1993) 0.75
[Cholesterol and triglycerides of serum lipoproteins isolated by means of ultracentrifugation. Correlation with arteriosclerosis]. Schweiz Med Wochenschr (1974) 0.75
[Influence of hormonal contraception on serum lipoproteins]. Schweiz Med Wochenschr (1978) 0.75
[Effects of fenofibrate in four types of hyperlipoproteinaemia and on apoproteins A and B in type IIa HLP (author's transl)]. Nouv Presse Med (1980) 0.75
[Relation between HDL cholesterol and fasting glycemia in a normal population and a diabetic group]. Schweiz Med Wochenschr (1984) 0.75
[Low HDL cholesterol in close relatives and patients with myocardial infarct]. Schweiz Med Wochenschr (1978) 0.75
High density lipoprotein (HDL) subfractions in cardiovascular patients with low levels of HDL-cholesterol. Influence of hypertriglyceridaemia on subfraction concentration and composition. Atherosclerosis (1988) 0.75
[Hypolipemic property and myotoxic action of clofibrate in a case of nephrotic syndrome]. Schweiz Rundsch Med Prax (1973) 0.75
Actin stress fiber content of regenerated endothelial cells correlates with intramural retention of intermediate plus low density lipoproteins in rat aorta after balloon injury. Atherosclerosis (1989) 0.75
A novel high-density lipoprotein particle and associated protein in rat plasma. Biochim Biophys Acta (1990) 0.75
Some characteristics of lipolysis in dog adipose tissue. Effects of noradrenaline, prostaglandin E1 and nicotinic acid. Acta Physiol Scand (1970) 0.75
[Classification of hyperlipoproteinemia in the light of advances in pathogenetic studies]. Pol Tyg Lek (1985) 0.75
[Remnant disease associated with apoprotein E1; clinical importance of apoprotein E (apo E) phenotypes]. Schweiz Med Wochenschr (1989) 0.75
[Coronary atherosclerosis and serum lipoproteins]. Schweiz Med Wochenschr (1979) 0.75
[Clinical study on the relationship between diabetes, hyperlipoproteinemia and atheromatosis]. Schweiz Med Wochenschr (1973) 0.75
[Teaching and Treatment Unit in the Division of Diabetology (Geneva)]. Rev Med Suisse Romande (1980) 0.75
Epitope expression in purified and lipid-bound forms of human apoprotein A-I. Adv Exp Med Biol (1987) 0.75
[HDL and lipoproteins in the families of coronary patients]. Schweiz Med Wochenschr (1981) 0.75
Immunological confirmation of the presence of NA1/NA2 (cytolysis inhibitor) in cerebrospinal fluid. Schweiz Arch Neurol Psychiatr (1991) 0.75
Effect of nicotinic acid on ACTH and noradrenaline stimulated lipolysis in the rabbit. I. In vivo studies. Acta Physiol Scand (1970) 0.75
[Bronchial carcinoma and abnormal secretion of antidiuretic hormone (Schwartz-Bartter syndrome)]. Helv Med Acta (1963) 0.75
Serum lipoprotein abnormalities in ischaemic heart disease. Postgrad Med J (1975) 0.75
[Reversible acquired acanthocytosis and hemolytic anemia associated with hypobetalipoproteinemia in a chronic alcoholic]. Schweiz Med Wochenschr (1983) 0.75
[Effect of renal insufficiency on diabetes mellitus]. Rev Med Suisse Romande (1979) 0.75
[Dyslipidemias and atherosclerosis. Treatment strategy]. Schweiz Rundsch Med Prax (1986) 0.75
[Lipoprotein metabolism and atherosclerosis]. Schweiz Rundsch Med Prax (1988) 0.75
[Plasma lipoproteins. Influence of heredity and external factors in the genesis of dyslipidemias]. Rev Med Suisse Romande (1980) 0.75
A non-competitive enzyme-linked immunosorbent assay for measuring human plasma apolipoprotein B levels. Clin Chim Acta (1985) 0.75